M1 KLINIKEN AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.72 EUR | -0.90% |
|
+5.32% | +23.66% |
| Feb. 05 | M1 Kliniken Mull Uplisting to Frankfurt Bourse's Prime Standard; Co-CEOs Buy 1.5 Million Shares | MT |
| 2023 | M1 Kliniken Takes Ownership of Dutch Online Pharmacy | MT |
| Sales 2023 * | 310M 332M | Sales 2024 * | 339M 362M | Capitalization | 254M 271M |
|---|---|---|---|---|---|
| Net income 2023 * | 7M 7.48M | Net income 2024 * | 10M 10.69M | EV / Sales 2023 * | 0.77 x |
| Net cash position 2023 * | 14.58M 15.58M | Net cash position 2024 * | 21.84M 23.34M | EV / Sales 2024 * | 0.68 x |
| P/E ratio 2023 * |
34.6
x | P/E ratio 2024 * |
26.1
x | Employees | 366 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 100% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 week | +1.84% | ||
| Current month | +5.73% | ||
| 1 month | +7.36% | ||
| 3 months | +33.17% | ||
| 6 months | +56.67% | ||
| Current year | +23.66% |
1 week
13.30
14.45
1 month
12.3514.45
Current year
10.1514.95
1 year
6.9614.95
3 years
3.7814.95
5 years
3.7817.15
10 years
3.7817.70
| Managers | Title | Age | Since |
|---|---|---|---|
Kilian Brenske
PRN | Corporate Officer/Principal | - | - |
Attila Strauss
PRN | Corporate Officer/Principal | - | 22-11-23 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sabine Meck
BRD | Director/Board Member | 69 | 15-06-22 |
Uwe Zimdars
CHM | Chairman | - | 17-06-26 |
Dirk Hempel
BRD | Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 13.85 | 0.00% | 35 247 |
| 24-04-17 | 13.85 | -1.77% | 15,012 |
| 24-04-16 | 14.1 | +2.17% | 8,821 |
| 24-04-15 | 13.8 | +2.60% | 12,649 |
| 24-04-12 | 13.45 | +2.28% | 17,136 |
Delayed Quote Xetra, April 17, 2024 at 11:36 am EDT
More quotes
M1 Kliniken AG, formerly M1 Beauty AG, is a Germany-based operator of healthcare facilities and provider of related services. The Company operates a chain of medical centers for aesthetic and plastic treatments, such as wrinkle treatments, lip treatments, breast corrections, liposuction, tummy tucks, upper arm lift, upper thigh lift, face lift, upper eyelid lift and the correction of labia, among others. In addition, the Company provides consultation services with registered doctors and specialists. It operates medical centers in Berlin, Essen, Dusseldorf, Cologne and Munich.
Calendar
2024-04-17
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
13.85
EUR
Average target price
16.75
EUR
Spread / Average Target
+20.94%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +23.66% | 270M | |
| -20.92% | 16.12B | |
| 0.00% | 11.99B | |
| +1.00% | 11.19B | |
| +9.77% | 10.89B | |
| +19.44% | 7.98B | |
| -3.86% | 7.5B | |
| +23.61% | 7.37B | |
| +5.00% | 6.7B | |
| -2.21% | 4.37B |
- Stock Market
- Equities
- M12 Stock
